Endogenous presentation of a nuclear antigen on MHC class II by autophagy in the absence of CRM1-mediated nuclear export

被引:22
作者
Riedel, Alexander [1 ,2 ]
Nimmerjahn, Falk [3 ]
Burdach, Stefan [2 ]
Behrends, Uta [1 ,2 ]
Bornkamm, Georg W. [1 ]
Mautner, Josef [1 ,2 ]
机构
[1] GSF Inst Klin Mol Biol & Tumorgenet, Klin Kooperat Grp, Munich, Germany
[2] Tech Univ Munich, Kinderklin, Munich, Germany
[3] Nikolaus Fiebiger Zentrurn Mol Med, Erlangen, Germany
关键词
antigen presentation; CRM1; MHC; nuclear antigen; T lymphocytes;
D O I
10.1002/eji.200737900
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Accumulating evidence suggests that intracellular antigens are endogenously presented on MHC class II, but it is still unknown whether antigens within different subcellular compartments are presented with similar efficiency, and via the same or different pathways. We have previously shown that endogenous MHC class II presentation of the cytosolic bacterial antigen neomycin phosphotransferase II (NeoR) is mediated by autophagy. Here, we addressed whether secluding NeoR from this cytoplasmic pathway by directing the protein into the cell nucleus (NucNeoR) would affect antigen presentation. Unexpectedly, NucNeoR was presented at least as efficiently as the cytosolic version of the antigen. Furthermore, presentation of NucNeoR was also dependent on autophagocytosis and lysosomal processing, indicating that both antigens were presented via the same pathway. inhibition of CRM1-mediated nuclear export did not impede antigen presentation, indicating that NucNeoR gained access to this autophagy-dependent MHC class II presentation pathway by a CRM1-independent route. Thus, this endogenous presentation pathway broadens the spectrum of intracellular antigens surveyed by CD4(+) T cells by efficiently sampling cytoplasmic as well as nuclear antigens.
引用
收藏
页码:2090 / 2095
页数:6
相关论文
共 18 条
[1]   Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins [J].
Adhikary, D ;
Behrends, U ;
Moosmann, A ;
Witter, K ;
Bornkamm, GW ;
Mautner, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (04) :995-1006
[2]   The cross-priming pathway: A portrait of an intricate immune system [J].
Basta, S. ;
Alatery, A. .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 65 (04) :311-319
[3]   Cross-priming [J].
Bevan, MJ .
NATURE IMMUNOLOGY, 2006, 7 (04) :363-365
[4]   ANTIGEN PRESENTATION PATHWAYS TO CLASS-I AND CLASS-II MHC-RESTRICTED LYMPHOCYTES-T [J].
BRACIALE, TJ ;
MORRISON, LA ;
SWEETSER, MT ;
SAMBROOK, J ;
GETHING, MJ ;
BRACIALE, VL .
IMMUNOLOGICAL REVIEWS, 1987, 98 :95-114
[5]   Autophagy promotes MHC class II presentation of peptides from intracellular source proteins [J].
Dengjel, J ;
Schoor, O ;
Fischer, R ;
Reich, M ;
Kraus, M ;
Müller, M ;
Kreymborg, K ;
Altenberend, F ;
Brandenburg, J ;
Kalbacher, H ;
Brock, R ;
Driessen, C ;
Rammensee, HG ;
Stevanovic, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (22) :7922-7927
[6]   Lysosomal cysteine proteases regulate antigen presentation [J].
Honey, K ;
Rudensky, AY .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (06) :472-482
[7]   Leptomycin B-induced apoptosis is mediated through caspase activation and down-regulation of Mcl-1 and XIAP expression, but not through the generation of ROS in U937 leukemia cells [J].
Jang, BC ;
Paik, JH ;
Jeong, HY ;
Oh, HJ ;
Park, JW ;
Kwon, TK ;
Song, DK ;
Park, JG ;
Kim, SP ;
Bae, JH ;
Mun, KC ;
Suh, MH ;
Yoshida, M ;
Suh, SI .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (02) :263-274
[8]   Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region [J].
Kudo, N ;
Matsumori, N ;
Taoka, H ;
Fujiwara, D ;
Schreiner, EP ;
Wolff, B ;
Yoshida, M ;
Horinouchi, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) :9112-9117
[9]   Intracellular localization and nucleocytoplasmic trafficking of steroid receptors: An overview [J].
Kumar, S ;
Saradhi, M ;
Chaturvedi, NK ;
Tyagi, RK .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 246 (1-2) :147-156
[10]   The endogenous pathway of MHC class II antigen presentation [J].
Lechler, R ;
Aichinger, G ;
Lightstone, L .
IMMUNOLOGICAL REVIEWS, 1996, 151 :51-79